High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients-Reference-Cited by-同舟云学术

High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients

Published:2019-01-22 Issue:7 Volume:10 Page:717-731
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Bach Laursen Maria¹,Reinholdt Linn¹,Schönherz Anna Amanda¹,Due Hanne¹,Starberg Jespersen Ditte¹,Grubach Lykke²,Schmidt Ettrup Marianne²,Røge Rasmus²,Falgreen Steffen¹,Sørensen Suzette¹³⁴,Støve Bødker Julie¹⁵,Schmitz Alexander¹⁵,Johnsen Hans E.¹⁵⁴,Bøgsted Martin¹⁵⁴,Dybkær Karen¹⁵⁴

Affiliation:

1. Department of Hematology, Aalborg University Hospital, Aalborg, Denmark

2. Department of Hematopathology, Aalborg University Hospital, Aalborg, Denmark

3. Centre for Clinical Research, North Denmark Regional Hospital, Hjørring, Denmark

4. Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

5. Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of unique B-cell populations in the circulation of people living with HIV prior to non-Hodgkin lymphoma diagnosis;Frontiers in Immunology;2024-09-11

2. A case of diffuse large B‐cell lymphoma with decompensated alcohol‐related liver cirrhosis treated successfully by chemoimmunotherapy;Clinical Case Reports;2024-04

3. Mechanisms of resistance to anti-CD20 antibodies in lymphoid malignancies;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

4. Prediction nomogram based on 18F-FDG PET/CT and clinical parameters for patients with diffuse large B-cell lymphoma;Annals of Hematology;2023-07-03

5. Reverse effect of Semaphorin-3F on rituximab resistance in diffuse large B-cell lymphoma via the Hippo pathway;Chinese Medical Journal;2023-04-28